Pharmacology, Toxicology and Pharmaceutical Science
Vasopressin
100%
Vasopressin V1 Receptor
63%
Argipressin
51%
Receptor Antagonist
42%
Receptor
35%
Radioligand
32%
Vasopressin V2 Receptor
29%
Iodine-125
29%
Vasopressin Receptor
24%
Binding Site
23%
Hypertension
22%
Epidermal Growth Factor
20%
Diuretics
17%
Table Salt
16%
Bosentan
15%
Angiotensin II
14%
Monoclonal Antibody
14%
Pharmacokinetic
13%
Vasopressin V1a Receptor
13%
Deoxycorticosterone Acetate
13%
Potassium Acetate
13%
Spontaneously Hypertensive Rat
13%
Enalapril
13%
1 [1 [4 (3 Acetamidopropoxy)benzoyl] 4 Piperidyl] 1,2,3,4 Tetrahydro 2 Quinolinone
13%
Mineralocorticoid
12%
Renin
12%
Atrial Natriuretic Factor
11%
Argipressin Receptor
11%
Isotopes of Potassium
11%
Hydrochlorothiazide
10%
Cardiovascular Risk
10%
Heart Infarction
10%
Vasopressin Receptor Antagonist
8%
Aldosterone
8%
Indometacin
8%
Normal Human
8%
Vasopressin Antagonist
8%
Renovascular Hypertension
8%
Dipeptidyl Carboxypeptidase Inhibitor
7%
Endothelin Receptor Antagonist
7%
Creatinine
7%
Metoclopramide
6%
Antiemetic Agent
6%
Serum Albumin
6%
Pharmacodynamics
6%
Amylin
6%
Antilipemic Agent
6%
Mozavaptan
6%
Xerostomia
6%
Cilazapril
6%
Neuroscience
Vasopressin
55%
Blood Plasma
38%
Hypertension
38%
Vasopressin V1 Receptor
34%
Argipressin
30%
Vasopressin V2 Receptor
29%
Receptor
28%
In Vitro
25%
Binding Site
25%
Receptor Antagonist
23%
Radioligand
22%
Epidermal Growth Factor
20%
Atrial Natriuretic Peptide
20%
Argipressin Receptor
18%
Renin
15%
Vasopressin Receptor
14%
In Vivo
13%
Ciclosporin
13%
Monoclonal Antibody
13%
Angiotensin
13%
Aldosterone
12%
Iodine-125
11%
Autoradiograph
9%
Plasma Renin Activity
9%
Vasoconstrictors
8%
Second Messenger System
8%
Endothelin Receptor
7%
Acetate
6%
Afferent Neurons
6%
Individual Differences
6%
Crossover Study
6%
Vasoactive
6%
Randomized Controlled Trial
6%
Hormone Receptor
6%
Deoxycorticosterone Acetate
6%
Amylin
6%
Ganglionectomy
6%
Diabetes Mellitus
6%
Endothelin
6%
Glucose
6%
Cyclic Adenosine Monophosphate
5%
Medulla
5%
Vasopressin V1a Receptor
5%
Antidiuretic
5%
Medicine and Dentistry
Randomized Controlled Trial
29%
Gestational Diabetes
27%
Atrial Natriuretic Factor
22%
Diabetes Prevention
20%
Diabetes
17%
Congestive Heart Failure
16%
Clinician
13%
Intervention Study
13%
Gastric Inhibitory Polypeptide
13%
Vasopressin
11%
Health Care Cost
11%
Lifestyle Modification
11%
Apoplexy
11%
Blood Pressure
10%
Home Oxygen Therapy
10%
Homeostasis
10%
Alcohol Consumption
10%
Aldosterone
10%
Diseases
10%
Angiotensin II
9%
Medicine
9%
Renin Angiotensin Aldosterone System
9%
Body Weight
9%
Quality of Life
8%
Cardiovascular System
8%
Aboriginal and Torres Strait Islander
8%
Outpatient
8%
Systolic Blood Pressure
8%
Karnofsky Performance Status
8%
Renin
8%
Argipressin
8%
Vasoconstrictor
8%
Thirst
8%
Adverse Effect
8%
Myocardial Infarction
7%
Peptide Receptor
7%
General Practitioner
7%
Clinical Trial
7%
ACE Inhibitor
7%
Maturity Onset Diabetes of the Young
7%
Cyclosporine
6%
Vasopressin V1 Receptor
6%
Casemix
6%
Diuretics
6%
Argipressin Receptor
6%
Serotype
6%
Vegetarian Diet
6%
Lifestyle Disease
6%
Kidney Function
6%
Care Group
6%